|
1
|
Jönsson B, Hofmarcher T, Lindgren P and
Wilking N: The cost and burden of cancer in the European Union
1995–2014. Eur J Cancer. 66:162–170. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zuo T, Zeng H, Zhang S
and He J: National cancer incidence and mortality in China, 2012.
Chin J Cancer Res. 28:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee JH, Lim JK, Kim MG and Kwon SJ: The
influence of post-operative surveillance on the prognosis after
curative surgery for gastric cancer. Hepatogastroenterology.
61:2123–2132. 2014.PubMed/NCBI
|
|
4
|
Yazici O, Sendur MA, Ozdemir N and Aksoy
S: Targeted therapies in gastric cancer and future perspectives.
World J Gastroenterol. 22:471–489. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SY and Oh SC: Changing strategies for
target therapy in gastric cancer. World J Gastroenterol.
22:1179–1189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Y, Kakinuma N, Wang Y and Kiyama R:
Kank proteins: A new family of ankyrin-repeat domain-containing
proteins. Biochim Biophys Acta. 1780:128–133. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sarkar S, Roy BC, Hatano N, Aoyagi T,
Gohji K and Kiyama R: A novel ankyrin repeat-containing gene (Kank)
located at 9p24 is a growth suppressor of renal cell carcinoma. J
Biol Chem. 277:36585–36591. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kakinuma N, Zhu Y, Wang Y, Roy BC and
Kiyama R: Kank proteins: Structure, functions and diseases. Cell
Mol Life Sci. 66:2651–2659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hatano N, Nishikawa NS, McElgunn C, Sarkar
S, Ozawa K, Shibanaka Y, Nakajima M, Gohiji K and Kiyama R: A
comprehensive analysis of loss of heterozygosity caused by
hemizygous deletions in renal cell carcinoma using a subtraction
library. Mol Carcinog. 31:161–170. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo X, Fan W, Bian X and Ma D:
Upregulation of the Kank1 gene-induced brain glioma apoptosis and
blockade of the cell cycle in G0/G1 phase. Int J Oncol. 44:797–804.
2014.PubMed/NCBI
|
|
11
|
Zimonjic DB, Simpson S, Popescu NC and
DiPaolo JA: Molecular cytogenetics of human papillomavirus-negative
cervical carcinoma cell lines. Cancer Genet Cytogenet. 82:1–8.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Simon R, Burger H, Semjonow A, Hertle L,
Terpe HJ and Bocker W: Patterns of chromosomal imbalances in muscle
invasive bladder cancer. Int J Oncol. 17:1025–1029. 2000.PubMed/NCBI
|
|
13
|
Huang SF, Hsu HC and Fletcher JA:
Investigation of chromosomal aberrations in hepatocellular
carcinoma by fluorescence in situ hybridization. Cancer Genet
Cytogenet. 111:21–27. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shao J, Li Y, Li H, Wu Q, Hou J and Liew
C: Deletion of chromosomes 9p and 17 associated with abnormal
expression of p53, p16/MTS1 and p15/MTS2 gene protein in
hepatocellular carcinomas. Chin Med J (Engl). 113:817–822.
2000.PubMed/NCBI
|
|
15
|
Heidenblad M, Schoenmakers EF, Jonson T,
Gorunova L, Veltman JA, van Kessel AG and Höglund M: Genome-wide
array-based comparative genomic hybridization reveals multiple
amplification targets and novel homozygous deletions in pancreatic
carcinoma cell lines. Cancer Res. 64:3052–3059. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sato M, Takahashi K, Nagayama K, Arai Y,
Ito N, Okada M, Minna JD, Yokota J and Kohno T: Identification of
chromosome arm 9p as the most frequent target of homozygous
deletions in lung cancer. Genes Chromosomes Cancer. 44:405–414.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lo KC, Stein LC, Panzarella JA, Cowell JK
and Hawthorn L: Identification of genes involved in squamous cell
carcinoma of the lung using synchronized data from DNA copy number
and transcript expression profiling analysis. Lung Cancer.
59:315–331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roy BC, Kakinuma N and Kiyama R: Kank
attenuates actin remodeling by preventing interaction between
IRSp53 and Rac1. J Cell Biol. 184:253–267. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kralovics R, Teo SS, Buser AS, Brutsche M,
Tiedt R, Tichelli A, Passamonti F, Pietra D, Cazzola M and Skoda
RC: Altered gene expression in myeloproliferative disorders
correlates with activation of signaling by the V617F mutation of
Jak2. Blood. 106:3374–3376. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boroughs LK and DeBerardinis RJ: Metabolic
pathways promoting cancer cell survival and growth. Nat Cell Biol.
17:351–359. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fitzmaurice C, Dicker D, Pain A, Hamavid
H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R,
Wolfe C, et al: Global Burden of Disease Cancer Collaboration: The
Global Burden of Cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clohisey SM, Dzhindzhev NS and Ohkura H:
Kank is an EB1 interacting protein that localises to muscle-tendon
attachment sites in Drosophila. PLoS One. 9:e1061122014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Kakinuma N, Zhu Y and Kiyama R:
Nucleo-cytoplasmic shuttling of human Kank protein accompanies
intracellular translocation of beta-catenin. J Cell Sci.
119:4002–4010. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roy BC, Aoyagi T, Sarkar S, Nomura K,
Kanda H, Iwaya K, Tachibana M and Kiyama R: Pathological
characterization of Kank in renal cell carcinoma. Exp Mol Pathol.
78:41–48. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kakinuma N, Roy BC, Zhu Y, Wang Y and
Kiyama R: Kank regulates RhoA-dependent formation of actin stress
fibers and cell migration via 14-3-3 in PI3K-Akt signaling. J Cell
Biol. 181:537–549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Y, Chen S, Xue R, Zhao J and Di M:
Mefloquine effectively targets gastric cancer cells through
phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling
pathway. Biochem Biophys Res Commun. 470:350–355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ghavami S, Hashemi M, Ande SR, Yeganeh B,
Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ, et
al: Apoptosis and cancer: Mutations within caspase genes. J Med
Genet. 46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ghasemian M, Mahdavi M, Zare P and Ali
Hosseinpour Feizi M: Spiroquinazolinone-induced cytotoxicity and
apoptosis in K562 human leukemia cells: Alteration in expression
levels of Bcl-2 and Bax. J Toxicol Sci. 40:115–126. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sela B: Survivin: Anti-apoptosis protein
and a prognostic marker for tumor progression and recurrence.
Harefuah. 141:103–107, 123. 2002.(In Hebrew). PubMed/NCBI
|
|
30
|
Jia J, Furlan A, Gonzalez-Hilarion S,
Leroy C, Gruenert DC, Tulasne D and Lejeune F: Caspases shutdown
nonsense-mediated mRNA decay during apoptosis. Cell Death Differ.
22:1754–1763. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun Y, Ai X, Shen S and Lu S:
NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung
cancer by targeting MYO10. Oncotarget. 6:8244–8254. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang B, Gao J, Rao Z, Zhang B, Ouyang W
and Yang C: Antisense oligonucleotide targeting matrix
metalloproteinase-7 (MMP-7) changes the ultrastructure of human
A549 lung adenocarcinoma cells. Ultrastruct Pathol. 35:256–259.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu D, Nakano J, Ishikawa S, Yokomise H,
Ueno M, Kadota K, Urushihara M and Huang CL: Overexpression of
matrix metalloproteinase-7 (MMP-7) correlates with tumor
proliferation, and a poor prognosis in non-small cell lung cancer.
Lung Cancer. 58:384–391. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Soleyman-Jahi S, Nedjat S, Abdirad A,
Hoorshad N, Heidari R and Zendehdel K: Prognostic significance of
matrix metalloproteinase-7 in gastric cancer survival: A
meta-analysis. PLoS One. 10:e01223162015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ye Y, Zhou X, Li X, Tang Y, Sun Y and Fang
J: Inhibition of epidermal growth factor receptor signaling
prohibits metastasis of gastric cancer via downregulation of MMP7
and MMP13. Tumour Biol. 35:10891–10896. 2014. View Article : Google Scholar : PubMed/NCBI
|
